000 01931cam a2200361 a 4500
003 EG-GiCUC
005 20250223030212.0
008 100313s2009 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.11.10.Ph.D.2009.Ab.A
100 0 _aAbeer Abdelhalim Abdelhamid
245 1 0 _aAssessment of CTACK in sera of psoriatic ptients undergoing PUVA or methotrexate therapy /
_cAbeer Abdelhalim Abdelhamid ; Supervised Amr Ezz Eldin Sharaf , Somaya Mohamed Elgawhaey , Shereen Osama Mohamed Tawfik
246 1 5 _aتقييم المحرك الكيميائى (سى تاك) فى مصل مرضى الصدفية الخاضعين للعلاج الضوئى او عقار الميثوتركسات
260 _aCairo :
_bAbeer Abdelhalim Abdelhamid ,
_c2009
300 _a171 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Dermatology and Venerology
520 _aBackground : The cutaneous T cell attacting chemokine (CTACK / CCL27) is a pivotal chemokine in mediating lymphocyte migration into the skin through the binding to the chemokine receptor CCR10. The infiltration of skin by T cell appears to be crucial for the initiation and maintenance of inflammatory and autoimmune skin diseases such as psoriasis . The aim of this study was to investigate the role of CTACK in T cell homing in psoriasis . Which is a T cell mediated disease
530 _aIssued also as CD
653 4 _aCTACK
653 4 _aMethotrexate
653 4 _aPUVA
700 0 _aAmr Ezz Eldin Sharaf ,
_eSupervisor
700 0 _aShereen Osama Mohamed Tawfik ,
_eSupervisor
700 0 _aSomaya Mohamed Elgawhaey ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
902 _a1
905 _aNazla
_eRevisor
905 _aSoheir
_eCataloger
942 _2ddc
_cTH
999 _c29717
_d29717